Literature DB >> 22042428

Should we rely on OCT to assess the improvements of new generation drug-eluting stents?

Pedro A Lemos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22042428     DOI： 10.1007/s10554-011-9967-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN： 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  4 in total

1.  Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.

Authors:  Patrick W Serruys; Sigmund Silber; Scot Garg; Robert Jan van Geuns; Gert Richardt; Pawel E Buszman; Henning Kelbaek; Adrianus Johannes van Boven; Sjoerd H Hofma; Axel Linke; Volker Klauss; William Wijns; Carlos Macaya; Philippe Garot; Carlo DiMario; Ganesh Manoharan; Ran Kornowski; Thomas Ischinger; Antonio Bartorelli; Jacintha Ronden; Marco Bressers; Pierre Gobbens; Manuela Negoita; Frank van Leeuwen; Stephan Windecker
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

2.  An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.

Authors:  Peter Barlis; Evelyn Regar; Patrick W Serruys; Konstantinos Dimopoulos; Willem J van der Giessen; Robert-Jan M van Geuns; Giuseppe Ferrante; Simon Wandel; Stephan Windecker; Gerrit-Anne van Es; Pedro Eerdmans; Peter Jüni; Carlo di Mario
Journal:  Eur Heart J       Date:  2009-11-04       Impact factor: 29.983

3.  2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice.

Authors:  Volker Klauss; Patrick W Serruys; Thomas Pilgrim; Pawel Buszman; Axel Linke; Thomas Ischinger; Franz Eberli; Roberto Corti; William Wijns; Marie-Claude Morice; Carlo di Mario; Robert Jan van Geuns; Gerrit-Anne van Es; Bindu Kalesan; Peter Wenaweser; Peter Jüni; Stephan Windecker
Journal:  JACC Cardiovasc Interv       Date:  2011-08       Impact factor: 11.195

4.  Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.

Authors:  Juan Luis Gutiérrez-Chico; Robert Jan van Geuns; Evelyn Regar; Willem J van der Giessen; Henning Kelbæk; Kari Saunamäki; Javier Escaned; Nieves Gonzalo; Carlo di Mario; Francesco Borgia; Eveline Nüesch; Héctor M García-García; Sigmund Silber; Stephan Windecker; Patrick W Serruys
Journal:  Eur Heart J       Date:  2011-06-09       Impact factor: 29.983
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.